From 20-23 May, several LML members will travel to Copenhagen for a retreat hosted by the University of Copenhagen's Centre for Advanced Studies in Biomedical Innovation Law.
As part of the CeBIL Collaborative Research Program, LML is responsible for a study investigating new uses for known drugs, and it will contribute to a study on synergy and policy solutions.
The retreat will provide an opportunity for LML to present a progress update on the 'New Uses' study and to receive feedback from other members of the CeBIL Collaborative Research Program.
Over the course of the week, the team will also meet with CeBIL's funders from the Novo Nordisk Foundation, and hear reports about CeBIL's societal engagement activities.